Compugen Ltd. (CGEN)
NASDAQ: CGEN · Real-Time Price · USD
1.490
-0.010 (-0.67%)
Dec 3, 2024, 2:02 PM EST - Market open

Compugen Revenue

Compugen had revenue of $17.13M in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $59.85M, up 698.03% year-over-year. In the year 2023, Compugen had annual revenue of $33.46M with 346.12% growth.

Revenue (ttm)
$59.85M
Revenue Growth
+698.03%
P/S Ratio
2.24
Revenue / Employee
$880,176
Employees
68
Market Cap
133.41M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202333.46M25.96M346.12%
Dec 31, 20227.50M1.50M25.00%
Dec 31, 20216.00M4.00M200.00%
Dec 31, 20202.00M--
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Repare Therapeutics 66.52M
Nanobiotix 45.22M
Vaxart 16.76M
Lineage Cell Therapeutics 8.72M
Cibus 4.15M
Cardiff Oncology 688.00K
Revenue Rankings